Enzalutamide + Leuprolide Boosts Overall Survival for Prostate Cancer With High Recurrence Risk

THURSDAY, Oct. 23, 2025 (HealthDay News) -- The combination of enzalutamide and leuprolide significantly improves overall survival among patients with prostate